GLI2-Specific Transcriptional Activation of the Bone Morphogenetic Protein/Activin Antagonist Follistatin in Human Epidermal Cells

    Thomas Eichberger, Alexandra Kaser, Claudia Pixner, Carmen Schmid, Stefan Klingler, Martina Winklmayr, Cornelia Hauser‐Kronberger, Fritz Aberger, Anna‐Maria Frischauf
    New to Follistatin? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This study found that GLI2 plays a key role in activating follistatin, an activin/BMP antagonist, in response to hedgehog signaling in human epidermal cells, with implications for hair follicle development and basal cell carcinoma. Our plain-language summary of this paper — not a Tressless recommendation.
    The study demonstrated that in human epidermal cells, the expression of the activin/BMP antagonist follistatin (FST) was predominantly up-regulated by the Hedgehog (HH) signaling effector GLI2. This up-regulation was specific to GLI2, as neither GLI1 nor GLI3 significantly increased FST transcription. The research identified two GLI consensus binding sites in the FST promoter necessary for GLI2-mediated activation, with a 518-bp fragment in the proximal promoter region being crucial for this specificity. Additionally, sequences C-terminal to the zinc finger in GLI2 were responsible for this specific activation, suggesting the involvement of GLI-interacting cofactors. The findings highlighted a significant role of GLI2 in the regulation of FST in response to HH signaling, indicating a regulatory interaction between HH and activin/BMP signaling pathways in hair follicle development and basal cell carcinoma (BCC).
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results